Ivermectin dosage for humans? Ivermectin 12mg?

Ivermectin is a medication that is used to treat parasitic infections in humans. The dosage of Ivermectin for humans varies depending on the condition being treated and the weight of the patient.

For the treatment of onchocerciasis (river blindness), the usual recommended dose of Ivermectin is a single oral dose of 150 mcg/kg of body weight. This dose is usually repeated every 6 to 12 months, depending on the individual patient’s condition.

For the treatment of strongyloidiasis, the usual recommended dose of Ivermectin is a single oral dose of 200 mcg/kg of body weight, which may be repeated in 2 weeks.

Benefits of Ivermectin

 

Ivermectin is a medication that has been used for many years to treat a variety of parasitic infections in humans and animals. In addition to its approved uses, Ivermectin has also been studied for its potential benefits in treating other conditions.

One of the main benefits of Ivermectin is its effectiveness in treating parasitic infections, such as onchocerciasis (river blindness) and strongyloidiasis. The drug works by targeting the nervous system of parasites, causing paralysis and ultimately death of the parasite. Ivermectin is often used in mass drug administration programs to control the spread of parasitic infections in high-risk populations.

In recent years, Ivermectin has also been studied for its potential benefits in treating other conditions, such as scabies, head lice, and rosacea. Studies have shown that Ivermectin can be effective in treating these conditions, particularly when other treatments have failed.

More recently, Ivermectin has gained attention for its potential benefits in treating coronavirus. Some studies have suggested that Ivermectin may have antiviral and anti-inflammatory properties that could help to reduce the severity of coronavirus and speed up recovery. However, the evidence for Ivermectin’s effectiveness in treating coronavirus is limited, and many experts have raised concerns about the quality of the studies that have been conducted.

Overall, the benefits of Ivermectin depend on the condition being treated, the individual patient’s needs, and the advice of a healthcare professional. It is important to only use Ivermectin under the guidance of a healthcare professional, as the drug can cause side effects and may interact with other medications.

ABOUT IVERMECTIN 12 MG


IVERMECTIN 12 MG

Ivermectin 12 mg is a medication that contains the active ingredient Ivermectin, which is used to treat parasitic infections in humans and animals. It is available in tablet form and is prescribed by a healthcare professional.

The usual recommended dosage of Ivermectin for adults is a single oral dose of 150 mcg/kg of body weight, which may be repeated every 6 to 12 months, depending on the individual patient’s condition. For example, if an adult weighs 60 kg, the recommended dose would be 9 mg of Ivermectin. However, the dosage and frequency of administration may vary depending on the individual patient’s condition and medical history and should be determined by a healthcare professional.

Ivermectin 12 mg tablets are often used in the treatment of parasitic infections such as onchocerciasis (river blindness), strongyloidiasis, and other parasitic infections. The medication works by binding to the nerve and muscle cells of parasites, causing paralysis and death of the parasite.

In recent months, there has been some controversy surrounding the use of Ivermectin for the treatment of coronavirus. While some studies have suggested that Ivermectin may have antiviral properties that could be effective against coronavirus, the evidence for its effectiveness in treating coronavirus is limited and conflicting. As such, the World Health Organization (WHO) and many health authorities do not currently recommend Ivermectin for the treatment of coronavirus.

Ivermectin 12mg Uses

 

Ivermectin 12mg is a medication that is primarily used to treat parasitic infections in humans and animals. The medication contains the active ingredient Ivermectin, which works by binding to the nerve and muscle cells of parasites, causing paralysis and death of the parasite.

Here are some of the most common uses of Ivermectin 12mg:

  1. Onchocerciasis (river blindness): Ivermectin is a key drug in the treatment of onchocerciasis, a parasitic infection that can cause blindness. It is usually given as a single dose of 150 mcg/kg of body weight, which may be repeated every 6 to 12 months, depending on the individual patient’s condition.
  2. Strongyloidiasis: Ivermectin is also used to treat strongyloidiasis, a parasitic infection that can cause itching, rash, and other symptoms. The recommended dosage for strongyloidiasis is a single dose of 200 mcg/kg of body weight, which may be repeated in 2 weeks.
  3. Scabies: Ivermectin has also been used to treat scabies, a parasitic skin infection that can cause itching and a rash. The medication may be given as a single dose or in multiple doses, depending on the individual patient’s condition.
  4. Head lice: Ivermectin has also been studied for its effectiveness in treating head lice. The medication may be given as a single dose or in multiple doses, depending on the individual patient’s condition.
  5. Other parasitic infections: Ivermectin may be used to treat other parasitic infections, such as filariasis, strongyloidiasis, and ascariasis, although the dosage and frequency of administration may vary depending on the individual patient’s condition and medical history.

It is important to only use Ivermectin 12mg under the guidance of a healthcare professional, as the medication can cause side effects and may interact with other medications. Additionally, Ivermectin 12mg is not recommended for use in children under the age of 15kg or pregnant or breastfeeding women, unless the benefits outweigh the potential risks.

Share:

Facebook
Twitter
Pinterest

2 thoughts on “Ivermectin dosage for humans? Ivermectin 12mg?”

  1. Good morning,

    A five-day course of ivermectin for the treatment of Coronavirus may reduce the duration of illness’, published in the International Journal of Infectious Diseases.

Leave a Comment

Your email address will not be published. Required fields are marked *

Table of Contents